Request Discount

Critical Care Therapeutics Market (Drug Class - Albumin, Factor Xiii Concentrates, Prothrombin Complex Concentrates, Fibrinogen Concentrates, and Antithrombin Concentrates; Application - Deep Vein Thrombosis, Surgeries, Atrial Fibrillation, Pulmonary Embolism (pe), Hemodialysis, Acute Coronary Syndrome, and Coronary Angioplasty): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : August, 2019

  • Rep Id : HC0641

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Critical Care Therapeutics Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Critical Care Therapeutics Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Critical Care Therapeutics Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on the critical care therapeutics market provides an in-depth analysis of segments and sub-segments in the global as well as regional critical care therapeutics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional critical care therapeutics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global critical care therapeutics market. According to the report, the global critical care therapeutics market is projected to grow at a CAGR of 3.6% over the forecast period of 2019-2025.

Market Insight

Intensive care or critical care is the treatment given and the close monitoring to individuals with acute, injuries or life-threatening illnesses such as burns, surgeries, accidents, sepsis, shock, complicated and severe breathing problems. These generally take place in a trauma center or ICU. Plasma is a fluid portion of the blood, in that blood cells are suspended. The other components include red blood cells (RBC), and platelets, and white blood cells (WBC) together comprise 45% of total blood. 

The global critical care therapeutics market is primarily driven by widely used in the management of critical care indications including bleeding in surgical settings including pregnancy, cardiac surgery, postpartum hemorrhage, perioperative bleeding, and trauma. Moreover, the rising development of recombinant products for critical care use is expected to fuel market growth in the near future. However, the existence of plasma fractionation supply and demand gap and no consensus has yet been reached regarding dose, duration of therapy, and when to use these factor concentrates is expected to hinder the demand for the global critical care therapeutics market. Nonetheless, the growing preference for marketed products over alternative treatment options is anticipated to create a new opportunity for the global critical care therapeutics market.

On the basis of region, the global critical care therapeutics market is bifurcated into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America held the largest revenue share for the global critical care therapeutics market in 2018 owing to the US is the major revenue contributor country across the globe due to the availability of healthcare facilities within the region. North America is followed by Europe and the Asia Pacific due to the adaptation rate of Europe is high after North America. The Asia Pacific is expected to be the fastest-growing region due to the increasing healthcare infrastructure and facility in the region.

Global Critical Care Therapeutics Market

Segment Covered

The report on global critical care therapeutics market covers segments such as drug class, and application. On the basis of drug class, the sub-markets include albumin, factor xiii concentrates, prothrombin complex concentrates, fibrinogen concentrates, and antithrombin concentrates. On the basis of application, the sub-markets include deep vein thrombosis, surgeries, atrial fibrillation, pulmonary embolism (pe), hemodialysis, acute coronary syndrome, and coronary angioplasty. 

Companies Profiled:

The report provides profiles of the companies in the market such as Kedrion Biopharma, CSL Behring, Octapharma, Grifols, Albumedix, Asklepios BioPharmaceutical, Therapeutics, ADMA Biologics, and Armetheon. 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of critical care therapeutics market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount